Mizuho Maintains Buy on Immunocore Hldgs, Raises Price Target to $74

Benzinga · 05/11/2023 06:57
Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price target from $70 to $74.